Form 4 for IONS IONIS PHARMACEUTICALS INC
Accepted 2023-08-03 00:00:00 ET · period of report 2023-08-01 · accession 0000874015-23-000181 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-03 | 2023-08-01 | IONS | Diaz Allene M. | Dir | S - Sale | $41.05 | -657 | 12.7K | -5% | -$27.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-01 | S | D | 657 | $41.05 | 12,676 | D | — | — | (F1) Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on April 26, 2023 |